IRD earnings: a positive outcome, +5.6%

On March 24, 2022, Opus Genetics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.6% in the window around the event. It had already run +13.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.